Johnson & Johnson voluntarily recalled certain lots of Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps after discovering a higher level than expected of a chemical.
The recall was initiated as a precaution and no safety concerns have been associated with the chemical, the New Brunswick, New Jersey-based company said today in a statement. The chemical, known as chlorpheniramine ammonio acetate, is formed from the combination of two product ingredients.
Recalls have plagued J&J the past two years, led by withdrawals of children's Tylenol, Motrin and other medicines affected by foul odors or faulty ingredients. The recall announced today is at the retail and wholesale level, not the consumer level. The risk of any adverse health effects is unlikely, the company said in its statement.
"No action is required by consumers or health-care providers and consumers can continue to use the product," J&J said in the statement.